DLD Asset Management »

Ultragenyx Pharmaceutical shares owned by DLD Asset Management

Quarter-by-quarter ownership of Ultragenyx Pharmaceutical (RARE) shares owned by DLD Asset Management from 13F filings

Historical chart of DLD Asset Management investment in Ultragenyx Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Ultragenyx Pharmaceutical held by DLD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ultragenyx Pharmaceutical by DLD Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.8M 78k 23.00
2025-09-30 $3.3M 111k 30.07
2025-06-30 $589k 16k 36.36

More positions owned by DLD Asset Management

Echostar Corp Note 3.875%11/3 (Principal)
Stride Note 1.125% 9/0 (Principal)
Ormat Technologies Note 2.500% 7/1 (Principal)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ionis Pharmaceuticals Note 1.750% 6/1 (Principal)
Rivian Automotive Com Cl A Put Option (RIVN)
Progress Software Corp Note 1.000% 4/1 (Principal)
Transocean Deb 4.625% 9/3 (Principal)
Centrus Energy Corp Note 2.250%11/0 (Principal)
Bofa Fin MTNF 0.600% 5/2 (Principal)
Makemytrip Limited Mauritius Note 2/1 (Principal)
Advanced Energy Inds Note 2.500% 9/1 (Principal)
Wolfspeed Note 2.500% 6/1 (Principal)
Starwood Ppty Tr Note 6.750% 7/1 (Principal)
Cidara Therapeutics Com New Call Option (CDTX)

View all positions for DLD Asset Management

Top funds holding Ultragenyx Pharmaceutical

Vanguard Group
FMR
BlackRock
State Street Corporation
Jpmorgan Chase & Co
Sands Capital Management
Rtw Investments
Baker Bros. Advisors
Suvretta Capital Management
Frontier Capital Management
Wellington Management Company
Bnp Paribas Investment Partners
Geode Capital Management
Jacobs Levy Equity Management
Standard Life Aberdeen

View all funds holding Ultragenyx Pharmaceutical